Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLOSURE-AF
NCT03463317Phase 4Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Feb 2018
- Primary completion
- Nov 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Atrial fibrillation (AFib) (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Primary endpoint (net clinical benefit) at 24 months. Started Feb 2018; status: completed.
02
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03463317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03463317.